Aortyx raises €13.8m to advance bioresorbable vascular patch
Aortyx intends to use the financing to achieve first-in-human readiness for its bioresorbable vascular patch, designed to treat aortic tears, thereby bringing the product closer to market.

Societal polarisation and its impact on the medical device development industry
Addressing the challenges posed by extreme weather events in the medical device development industry
Economic downturn: challenges and opportunities in the medical device development industry
Biodiversity loss and ecosystem collapse: the impact on the medical device development industry